Macrolide resistance trends in β-hemolytic streptococci in a Tertiary Korean Hospital

Yonsei Medical Journal

Volumn 48, Issue 5, 2007, Pages 773-778

  Uh, Young ^a   Hwang, Gyu Yel ^a   Jang, In Ho ^a   Cho, Hyun Mi ^a   Noh, Song Mi ^a   Kim, Noh Youl ^a   Kwon, Ohgun ^a   Yoon, Kap Jun ^a  

^a Yonsei University Wonju College of Medicine   (South Korea)

Author keywords

hemolytic streptoccci; Antibiotic resistance; Erythromycin; Macrolides; Streptococcus agalactiae; Streptococcus pyogenes

Indexed keywords

CHLORAMPHENICOL; CLINDAMYCIN; ERYTHROMYCIN; LINCOSAMIDE; MACROLIDE; MIKAMYCIN B; TETRACYCLINE; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; BETA HEMOLYTIC STREPTOCOCCUS; CONTROLLED STUDY; GENOTYPE; KOREA; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PHENOTYPE; POLYMERASE CHAIN REACTION; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS DYSGALACTIAE EQUISIMILIS; STREPTOCOCCUS PYOGENES; TERTIARY HEALTH CARE;

ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ERYTHROMYCIN; GENES, BACTERIAL; GENOTYPE; HOSPITALS; HUMANS; INCIDENCE; KOREA; MICROBIAL SENSITIVITY TESTS; STREPTOCOCCUS; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS PYOGENES;

EID: 36248975188     PISSN: 05135796     EISSN: None     Source Type: Journal    
DOI: 10.3349/ymj.2007.48.5.773     Document Type: Article

References (22)

1. Ruoff KL, Whiley RA, Beighton D. Streptococcus. In: Murray PR, Baron EJ, Jorgensen JH, Pfaller MA, Yolken RH, editors. Manual of clinical microbiology, 8th ed. Washington DC: American Society for Microbiology; 2003. p.405-21.
2. Bisno AL, Gerber MA, Gwaltney JM Jr, Kaplan EL, Schwartz RH. Practice guidelines for the diagnosis and management of group A streptococcal pharyngitis. Clin Infect Dis 2002;35:113-25.
3. Schuchat A. Group B streptococcal disease: from trials and tribulations to triumph and trepidation. Clin Infect Dis 2001;33:751-6.
4. Biedenbach DJ, Stephen JM, Jones RN. Antimicrobial susceptibility profile among β-haemolytic Streptococcus spp. collected in the SENTRY Antimicrobial Surveillance Program-North America, 2001. Diagn Microbiol Infect Dis 2003;46:291-4.
5. Carroll KC, Monroe P, Cohen S, Hoffman M, Hamilton L, Korgenski K, et al. Susceptibility of β-hemolytic streptococci to nine antimicrobial agents among four medical centers in Salt Lake City, Utah, USA. Diagn Microbiol Infect Dis 1997;27:123-8.
6. Gordon KA, Beach ML, Biedenbach DJ, Jones RN, Rhomberg PR, Mutnick AH. Antimicrobial susceptibility patterns of β-hemolytic and viridans group streptococci: report from the SENTRY Antimicrobial Surveillance Program (1997-2000). Diagn Microbiol Infect Dis 2002;43:157-62.
7. Traub WH, Leonhard B. Comparative susceptibility of clinical group A, B, C, F, and G β-hemolytic streptococcal isolates to 24 antimicrobial drugs. Chemotherapy 1997;43:10-20.
8. Wu JJ, Lin KY, Hsueh PR, Liu JW, Pan HI, Sheu SM. High incidence of erythromycin-resistant streptococci in Taiwan. Antimicrob Agents Chemother 1997;41:844-6.
9. Avanzini C, Bosio K, Volpe G, Dotti G, Savoia D. Streptococcus pyogenes collected in Torino (northwest Italy) between 1983 and 1998: survey of macrolide resistance and trend of genotype by RAPD. Microb Drug Resist 2000;6:289-95.
10. Kataja J, Huovinen P, Efstratiou A, Pérez-Trallero E, Seppälä H; Macrolide resistance study group. Clonal relationships among isolates of erythromycin-resistant Streptococcus pyogenes of different geographical origin Eur J Clin Microbiol Infect Dis 2002;21:589-95.
11. Seppälä H, Klaukka T, Vuopio-Varkila J, Muotiala A, Helenius H, Lager K, et al. The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. N Engl J Med 1997;337:441-6.
12. Chong Y, Lee K. Present situation of antimicrobial resistance in Korea. J Infect Chemother 2000;6:189-95.
13. Kim HY, Uh Y. Macrolide resistance in β-hemolytic streptococci: changes after the implementation of the separation of prescribing and dispensing of medications policy in Korea. Yonsei Med J 2004;45:591-7.
14. Uh Y, Jang IH, Hwang GY, Lee MK, Yoon KJ, Kim HY. Antimicrobial susceptibility patterns and macrolide resistance genes of β-hemolytic streptococci in Korea. Antimicrob Agents Chemother 2004; 48:2716-8.
15. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; sixteenth informational supplement. CLSI document M100-S16. Wayne (PA): Clinical and Laboratory Standards Institute; 2006.
16. Uh Y, Jang IH, Yoon KJ, Kim HY. Serogroup distribution of beta-hemolytic streptococci isolated from a tertiary care hospital at Wonju area during the recent 4 years (1997-2000). Korean J Infect Dis 2001;33: 173-80.
17. Uh Y, Yong D, Lee K, Kwon O, Yoon KJ. Emergence of erythromycin-resistant Streptococcus agalactiae serotype V is due to clonal spread. Korean J Lab Med 2005;25:S564.
18. Ko WC, Lee HC, Wang LR, Lee CT, Liu AJ, Wu JJ. Serotyping and antimicrobial susceptibility of group B Streptococcus over an eight-year period in southern Taiwan. Eur J Clin Microbiol Infect Dis 2001;20:334-9.
19. Malbruny B, Werno AM, Anderson TP, Murdoch DR, Leclercq R. A new phenotype of resistance to lincosamide and streptogramin A-type antibiotics in Streptococcus agalactiae in New Zealand. J Antimicrob Chemother 2004;54:1040-4.
20. Woo PG, Fung AM, Lau SK, Wong SS, Yuen KY. Group G beta-hemolytic streptococcal bacteremia characterized by 16S ribosomal RNA gene sequencing. J Clin Microbiol 2001;39:3147-55.
21. Zaoutis T, Schneider B, Steele Moore L, Klein JD. Antibiotic susceptibilities of group C and group G streptococci isolated from patients with invasive infections: evidence of vancomycin tolerance among group G serotypes. J Clin Microbiol 1999;37:3380-3.
22. Hashikawa S, Iinuma Y, Furushita M, Ohkura T, Nada T, Torii K, et al. Characterization of group C and G streptococcal strains that cause streptococcal toxic shock syndrome. J Clin Microbiol 2004;42:186-92.